COMMUNIQUÉS West-GlobeNewswire

Targovax ASA: Resolutions to increase the share capital in Targovax ASA in relation to exercise of employee options and settlement of restricted stock units

18/08/2017 - 07:00

This announcement is distributed by NASDAQ OMX Corporate Solutions on behalf of NASDAQ OMX Corporate Solutions clients. The issuer of this announcement warrants that they are solely responsible for the content, accuracy [...]

Information concerning the total number of voting rights and shares, provided pursuant to article L. 233-8 II of the Code de commerce (the French Commercial Code) and article 223-16 of the Règlemen...

17/08/2017 - 18:00

Information concerning the total number of voting rights and shares, provided pursuant to article L. 233-8 II of the Code de commerce (the French Commercial Code) and article 223-16 of the Règlement général de l' [...]

Informations relatives au nombre total de droits de vote et d'actions prévues par l'article L. 233-8 II du Code de commerce et l'article 223-16 du Règlement général de l'Autorité des Marchés Financ...

17/08/2017 - 18:00

Informations relatives au nombre total de droits de vote et d'actions prévues par l'article L. 233-8 II du Code de commerce et l'article 223-16 du Règlement général de l'Autorité des Marchés Financiers Sanofi Société [...]

Medtronic EVP & CFO Karen L. Parkhill to Speak at Intellisight 2017 Conference

17/08/2017 - 16:00

DUBLIN - August 17, 2017 - Medtronic plc (NYSE:MDT), the global leader in medical technology, today announced it will participate in the CFA Society Minnesota's 6th Annual Investor Conference, Intellisight, on Wednesday [...]

Tetraphase Pharmaceuticals Announces Submission and Validation of IV Eravacycline Marketing Authorization Application by European Medicines Agency

17/08/2017 - 14:30

WATERTOWN, Mass., Aug. 17, 2017 (GLOBE NEWSWIRE) -- Tetraphase Pharmaceuticals, Inc. (NASDAQ:TTPH), a clinical-stage biopharmaceutical company developing novel antibiotics to treat life-threatening multidrug- resistant [...]

ClearCorrect acquired by global dental leader Straumann Group

17/08/2017 - 14:00

ROUND ROCK, Texas, Aug. 17, 2017 (GLOBE NEWSWIRE) -- ClearCorrect, LLC, a leading manufacturer of clear aligners, is pleased to announce their acquisition by the Straumann Group, a global leader in tooth replacement [...]

Oxford BioMedica plc: INTERIM RESULTS FOR THE SIX MONTHS ENDED 30 JUNE 2017

17/08/2017 - 13:00

OXFORD BIOMEDICA PLC INTERIM RESULTS FOR THE SIX MONTHS ENDED 30 JUNE 2017 Oxford, UK - 17 August 2017: Oxford BioMedica plc ("OXB" or "the Group"; LSE: OXB), a leading gene and cell therapy group, today announces [...]

RedHill Biopharma Announces U.S. Commercialization Agreement for FDA-Approved GI Product Esomeprazole Strontium Delayed-Release Capsules

17/08/2017 - 13:00

RedHill was granted the exclusive rights to promote Esomeprazole Strontium Delayed-Release (DR) Capsules to gastroenterologists in certain U.S. territories Esomeprazole Strontium DR Capsules 49.3 mg is an FDA-approved, [...]

Aptevo Therapeutics and Alligator Bioscience commence IND-enabling development activities for new bispecific immunotherapy candidate ALG.APV-527

17/08/2017 - 13:00

Aptevo Therapeutics and Alligator Bioscience commence IND-enabling development activities for new bispecific immunotherapy candidate ALG.APV-527 Novel Bispecific Antibody Targeting Biological Pathway Implicated in [...]

Immunicum AB (publ) Completes Strategic Analysis and Defines Updated Clinical Development Plan for Ilixadencel

17/08/2017 - 08:00

Press Release 17 August 2017 Immunicum Completes Strategic Analysis and Defines Updated Clinical Development Plan for Ilixadencel Immunicum AB (publ; First North Premier: IMMU.ST), a biopharmaceutical company advancing [...]

argenx to host conference call & webcast to report second quarter business update and half year 2017 financial results on August 24, 2017

17/08/2017 - 07:00

Breda, the Netherlands / Ghent, Belgium - argenx (Euronext & Nasdaq: ARGX), a clinical-stage biotechnology company developing a deep pipeline of differentiated antibody-based therapies for the treatment of severe [...]

ABLYNX WILL ANNOUNCE ITS 2017 HALF YEAR RESULTS WITH WEBCAST ON 24 AUGUST 2017

17/08/2017 - 07:00

GHENT, Belgium, 17 August 2017 - Ablynx [Euronext Brussels: ABLX; OTC: ABYLY] will report its 2017 half year financial results and year-to-date business update on Thursday 24 August 2017 at 7.00 am CET. The Ablynx [...]

Semaglutide superior to dulaglutide on glucose control and weight loss in people with type 2 diabetes in SUSTAIN 7

16/08/2017 - 20:01

Bagsværd , Denmark, 16 August 2017 - Novo Nordisk today announced the SUSTAIN 7 trial results, demonstrating that people with type 2 diabetes treated with once-weekly semaglutide experienced superior reduction in HbA 1c [...]

CROSSJECT : Information relative au nombre total de droits de vote et d'actions composant le capital social

16/08/2017 - 17:57

Information relative au nombre total de droits de vote et d'actions composant le capital social 16 août 2017 CROSSJECT (ISIN : FR0011716265 ; Mnémo : ALCJ), « specialty pharma » qui développe un portefeuille de [...]

Abeona Therapeutics Announces Pivotal Expansion of ABO-102 Gene Therapy Clinical Trials in Sanfilippo Syndrome Type A

16/08/2017 - 15:37

NEW YORK and CLEVELAND, Aug. 16, 2017 (GLOBE NEWSWIRE) -- Abeona Therapeutics Inc. (Nasdaq:ABEO), a leading clinical-stage biopharmaceutical company focused on developing novel gene therapies for life-threatening rare [...]

Photocure ASA: Presentation of the second quarter and first half year 2017 results

16/08/2017 - 14:45

Photocure will present its second quarter and first half year report on Wednesday 23 August 2017 at Hotel Continental, Oslo, Norway. The presentation will begin at 08:30 (CET) and representatives from the company will [...]

Vascular Dynamics annonce l'approbation de la FDA pour le lancement de l'essai CALM 2 pour le MobiusHD® System pour le traitement de l'hypertension artérielle résistante

16/08/2017 - 12:58

MOUNTAIN VIEW, Californie, 15 août 2017 (GLOBE NEWSWIRE) - Vascular Dynamics, Inc. (VDI), société privée de dispositifs médicaux développant de nouvelles solutions pour le traitement de l'hypertension, annonce aujourd' [...]

Curetis Announces Financial Results for the First Six Months of 2017

16/08/2017 - 08:16

Curetis Announces Financial Results for the First Six Months of 2017 - Further advancement of product pipeline and integration of GEAR and Gyronimo platforms - Expansion of global installed base to 161 as of June 30, [...]

NEXSTIM PLC HALF-YEARLY REPORT 1 JANUARY - 30 JUNE 2017 (UNAUDITED)

16/08/2017 - 08:00

Company announcement, Helsinki, 16 August 2017 at 9:00 am Company Highlights, January - June 2017 Patient enrolment for Nexstim's supplementary Phase III Trial in Stroke Rehabilitation (E-FIT) using its NBT ® system is [...]